Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Boost immunity" describes interventions or substances that aim to enhance the body’s immune response. This phrase refers to a therapeutic strategy or effect and not to any particular molecular target. The immune response is a highly orchestrated set of mechanisms, including innate defenses (such as phagocytes, complement system, and natural killer cells) and adaptive immunity (T cells and B cells)[1][3]. Drugs or therapies said to "boost immunity" may act through a variety of pathways and targets, such as stimulating cytokine production, activating pattern recognition receptors (like toll-like receptors), modulating immune checkpoints (e.g., PD-1/PD-L1, CTLA-4), or enhancing specific cellular immunity[1][7]. Therefore, "boost immunity" should not be annotated as a molecular target, but as a general intended effect or pharmacological action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Boost immunity.